CN114957082B - Lysosome targeting fluorescent probe and preparation method and application thereof - Google Patents
Lysosome targeting fluorescent probe and preparation method and application thereof Download PDFInfo
- Publication number
- CN114957082B CN114957082B CN202210711226.7A CN202210711226A CN114957082B CN 114957082 B CN114957082 B CN 114957082B CN 202210711226 A CN202210711226 A CN 202210711226A CN 114957082 B CN114957082 B CN 114957082B
- Authority
- CN
- China
- Prior art keywords
- fluorescent probe
- lysosome
- compound
- cells
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003712 lysosome Anatomy 0.000 title claims abstract description 54
- 230000001868 lysosomic effect Effects 0.000 title claims abstract description 51
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 26
- 230000008685 targeting Effects 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 210000004027 cell Anatomy 0.000 claims abstract description 52
- 239000002253 acid Substances 0.000 claims abstract description 14
- 239000000523 sample Substances 0.000 claims abstract description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- -1 indole compound Chemical class 0.000 claims description 12
- 230000002132 lysosomal effect Effects 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 150000002500 ions Chemical class 0.000 claims description 7
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 6
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 4
- 230000011712 cell development Effects 0.000 claims description 3
- 238000011161 development Methods 0.000 claims description 3
- 230000018109 developmental process Effects 0.000 claims description 3
- 125000001033 ether group Chemical group 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000000975 dye Substances 0.000 abstract description 22
- 210000003463 organelle Anatomy 0.000 abstract description 8
- 238000003384 imaging method Methods 0.000 abstract description 3
- 230000003834 intracellular effect Effects 0.000 abstract description 2
- 239000003269 fluorescent indicator Substances 0.000 abstract 1
- 238000010186 staining Methods 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- 238000004043 dyeing Methods 0.000 description 15
- 229940125904 compound 1 Drugs 0.000 description 10
- 239000012065 filter cake Substances 0.000 description 10
- 238000001819 mass spectrum Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000012224 working solution Substances 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000011550 stock solution Substances 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 229940126214 compound 3 Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 229940125782 compound 2 Drugs 0.000 description 6
- 238000007865 diluting Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 238000002390 rotary evaporation Methods 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- WDCYWAQPCXBPJA-UHFFFAOYSA-N 1,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC([N+]([O-])=O)=C1 WDCYWAQPCXBPJA-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000027152 lysosome localization Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- PWEBUXCTKOWPCW-UHFFFAOYSA-N squaric acid Chemical compound OC1=C(O)C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-N 0.000 description 2
- WITBGLGAUOJYMJ-UHFFFAOYSA-N 4-[(dipropylamino)methyl]aniline Chemical compound CCCN(CCC)CC1=CC=C(N)C=C1 WITBGLGAUOJYMJ-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical group COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 208000015439 Lysosomal storage disease Diseases 0.000 description 1
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical group CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
- 201000010001 Silicosis Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- MHYFEEDKONKGEB-UHFFFAOYSA-N oxathiane 2,2-dioxide Chemical compound O=S1(=O)CCCCO1 MHYFEEDKONKGEB-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0066—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of biology, and particularly relates to a lysosome targeting fluorescent probe, a preparation method and application thereof, which are acid organelle dyes in living cells. Most lysosome probes currently marketed have emission peaks in the blue and yellow light ranges, while fluorescent antibodies or other functional fluorescent dyes usually appear in this band, usually the intracellular autofluorescence is in the blue-green region, if the fluorescent indicators are in the ultraviolet region at or near this band, which will overlap each other and affect imaging.
Description
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a lysosome targeting fluorescent probe, a preparation method and application thereof, which are acid organelle dyes in living cells.
Background
Lysosomes, which are an organelle in eukaryotic cells, contain various hydrolases, which not only break down exogenous macromolecular substances, but also digest the local cytoplasm or organelle of the cell itself. In senescent cells, the programmed disrupted lysosomes release hydrolytic enzymes, allowing the cells to be digested and die.
Lysosomes have low pH values and enzymes within lysosomes mostly only function in such acidic environments. Lysosomes are involved in various vital activities such as metabolism of substances in cells, circulation in living bodies, apoptosis, etc. Lysosomes are highly dynamic in nature, and changes in number and morphology are directly indicative of the state of vital activity in which the cell is located, and lysosomal abnormalities often cause a variety of diseases, such as gout, lysosomal storage disorders, silicosis, and the like. Therefore, the research and analysis of the strong lysosomes can understand the molecular mechanism of the lysosomes participating in biological activities, and has important guiding effect on the treatment of related diseases. In order to achieve the above functions, the developed probe is required to have high specificity to lysosomes and little interference to physiological functions.
Commercial lysosome probes realize lysosome localization analysis by labeling lysosome membranes, such as classical LysoTracker series, specifically labeling acidic organelles at millimolar concentrations, and realizing the function of lysosome localization in fluorescence imaging. However, most lysosome probes currently marketed have emission peaks in the blue and yellow light ranges, and fluorescent antibodies or other functional fluorescent dyes are usually present in this wavelength band, which brings about great difficulty to the experimenters who need to dye lysosomes in multicolor imaging in the selection of the wavelength band of the dye. In general, the autofluorescence in the cell is in the blue-green region, and if the fluorescence indicators are in the ultraviolet region at or near the wavelength band, the fluorescence indicators overlap with each other, so that imaging is affected, and in order to solve the dilemma, a new luminous lysosome dye needs to be developed, so that the requirement of multichannel fluorescence imaging can be met. For the above reasons, the development of lysosomal dyes in the red spectral region is a desirable choice, but no such probes have been reported in the prior art.
Disclosure of Invention
The invention relates to a red fluorescent dye, which has excitation and emission wavelengths of 630-640/655-665nm, can freely penetrate cell membranes, mark living cells, and can specifically mark and track acidic organelles in the living cells at a low nanomolar concentration. Another feature of the invention is that one-step staining can be achieved without the need for secondary antibody detection as with other probes such as Dinitrobenzene (DNP), and specific labeling of acid cell organelle lysosomes within living cells, and detection of cells at nanomolar levels is achieved while rapid introduction. Meanwhile, compared with other lysosome dyes, the dye has more obvious dyeing effect, is not easy to quench and has better optical stability, and can be kept in cells for a long time. The excitation emission wavelength of the invention is closer to the near infrared spectrum, and the invention can also meet the requirement of multicolor dyeing.
The invention adopts the following technical scheme:
a lysosomal targeting fluorescent probe having the following chemical formula:
the invention discloses a preparation method of the lysosome targeting fluorescent probe, which comprises the steps of reacting an indole compound with a hydroxycyclobutene compound to obtain the lysosome targeting fluorescent probe; the chemical structural formula of the indole compound is one or two of the following structural formulas:
、/>、/>
wherein the substituent is consistent with the lysosome targeting fluorescent probe.
In the present invention, the chemical structural formula of the hydroxycyclobutene compound is as follows:
or->
In the present invention, R 1 、R 2 Independently selected from hydrogen, alkyl, ether, and the like; r is R 3 、R 4 Independently selected from hydrogen, alkyl, alkylsulfonic acid ions, and the like.
In the above technical scheme, the alkyl is straight-chain alkyl or cycloalkyl, and the alkylThe number of carbon atoms is 1 to 20, preferably 2 to 15, more preferably R 1 、R 2 The number of carbon atoms of the alkyl group in the formula (I) is 2-6, R 3 、R 4 The number of carbon atoms of the alkyl group is 2 to 12.
In the above embodiments, the alkyl group in the ether group has 2 to 6 carbon atoms, preferably 2 to 5 carbon atoms, such as methyl ether group, ethyl ether group, methyl ethyl ether group, etc.
In the above technical scheme, the alkylsulfonic acid is (CH 2 )nSO 3 H, n is 1 to 10, preferably 2 to 8, more preferably 3 to 5.
In the above technical scheme, the alkylsulfonic acid ion is (CH) 2 )mSO 3 - M is 1 to 10, preferably 2 to 8, more preferably 3 to 5.
In the above technical solution, the lysosome targeting fluorescent probe has balanced electrovalence, and when the lysosome targeting fluorescent probe has positive charge and does not contain alkylsulfonic acid ions, the lysosome targeting fluorescent probe has anion coordination, and the specific anion coordination is a conventional technology, such as halogen ions; if the inclusion of an alkylsulfonic acid ion causes the molecular body to carry a negative charge, it has a cationic coordination, and the specific cationic coordination is a conventional technique such as sodium ion.
In the above technical scheme, the temperature of the reaction of the indole compound and the hydroxycyclobutene compound is 120-200 ℃, preferably 150-180 ℃ for 2-6 hours, preferably 3-5 hours.
The invention discloses an application of the lysosome targeting fluorescent probe as a lysosome probe, or an application in preparing the lysosome probe, or an application in cell development, or an application in preparing a cell developer.
The invention discloses a cell developing method, which comprises the steps of co-culturing cells and the lysosome targeted fluorescent probe, and then developing to complete cell development; preferably, the co-incubation time is from 5 to 30 minutes, preferably from 10 to 25 minutes, and the development is carried out in a conventional manner; the concentration of lysosomal targeted fluorescent probes can be as low as nanomolar, even below 0.05 μm. By way of example, biological cells and the lysosome targeted fluorescent probe of the invention are co-cultured for 15 minutes, and can be developed by utilizing a laser confocal microscope or a common fluorescent microscope.
The invention develops a novel red-light lysosome dye, which has the advantages of stable targeting performance and high fluorescence intensity, and meets the requirement of diversified selection of clients. The excitation and emission wavelengths are 630-640/655-665nm, can freely penetrate cell membranes, label living cells, and can specifically label and track acidic cell organelles in the living cells at a low nanomolar concentration. Another feature of the invention is that one-step staining can be achieved without the need for secondary antibody detection as with other probes such as Dinitrobenzene (DNP), and specific labeling of acid cell organelle lysosomes within living cells, and detection of intracellular at nanomolar concentration levels is achieved while rapid introduction. Meanwhile, compared with other lysosome dyes, the dye has more obvious dyeing effect, is not easy to quench and has better optical stability, and can be kept in cells for a long time.
Drawings
FIG. 1 is a mass spectrum of Compound 1;
FIG. 2 is a mass spectrum of Compound 2;
FIG. 3 is a mass spectrum of Compound 3;
FIG. 4 is a mass spectrum of Compound 4;
FIG. 5 is a mass spectrum of Compound 5;
FIG. 6 is spectral data for Compound 1, excitation 634nm, emission 661nm;
FIG. 7 is a compound 1 cell visualization;
FIG. 8 is a compound 2 cell visualization;
FIG. 9 is a compound 3 cell visualization;
FIG. 10 is a co-staining pattern of Compound 1 and control;
FIG. 11 is a compound 3 cell visualization;
FIG. 12 is a photograph showing a conventional dye cell.
Detailed Description
The raw materials of the invention are conventional compounds, and the specific preparation operation and test are conventional techniques.
Example 1
500 9 g of 4-dipropylaminomethyl-aniline and 70 mL of concentrated hydrochloric acid are added into a mL reaction flask, stirred and cooled to-10 ℃, 6.1 g sodium nitrite solution dissolved in 30 mL water is dropwise added, the internal temperature is not higher than-5 ℃, stirring is carried out for 30 minutes after the completion of the dropwise addition, and 25 mL of concentrated hydrochloric acid (37 wt%) solution of 32.6 g stannous chloride dihydrate precooled to 5 ℃ is dropwise added. After the dripping is finished, the reaction solution is stirred for 1.5 hours at the temperature of minus 10 ℃, then the temperature is increased to 5 ℃ for reaction for 18 hours, after the reaction is finished, the solvent is removed by rotary evaporation, the isopropanol 120 ml is added, the stirring is carried out for 2 hours, the filtration is carried out, the filter cake is washed once by the isopropanol, the filtration is carried out, and the filter cake is dried in vacuum to obtain the product 11.2 g of the intermediate I.
11.2 g of intermediate I,11.3 g of methyl isopropyl ketone and 110 mL of acetic acid are added into a 250 mL reaction bottle, heated to 120 ℃, cooled to room temperature after the reaction is finished for 2 hours, solvent is removed by rotary evaporation, ethyl acetate 160 ml and pure water 160 ml are added, the mixture is filtered after stirring for 30 minutes, the filtrate is separated, the aqueous phase is extracted once by 120 ml of ethyl acetate, the organic phases are combined, saturated saline is washed once, dried by anhydrous sodium sulfate, filtered, the filtrate is rotary evaporated to dryness, silica gel is purified by column chromatography, eluent is dichloromethane to methanol=96:4 (mass ratio), rotary drying is collected, and 10.7g of intermediate II is obtained by vacuum drying.
250 10.7g intermediate II,2.2 g of 3, 4-dihydroxyl-3-cyclobutene-1, 2-dione, 55 mL toluene and 55 mL n-butanol are added into a mL reaction bottle, stirring is carried out, heating is carried out to 160 ℃ for 4 hours, after the reaction is finished, heating is stopped, cooling is carried out to room temperature, solid is separated out, filtering is carried out, filter cakes are washed by diethyl ether for 2 times, filter cakes are collected, and vacuum drying is carried out, thus obtaining the final product 6.1 g of compound 1, and the mass spectrum is shown in figure 1.
Example two
250 5g of 4-dimethoxy aminomethyl-aniline and 55. 55 mL of concentrated hydrochloric acid (37%) are added into a mL reaction flask, then a solution of 3.8. 3.8 g sodium nitrite dissolved in 20 mL water is dripped at-10 ℃ and the internal temperature is not higher than-5 ℃, stirring is carried out for 30 minutes after the dripping is finished, and then 18. 18 mL of concentrated hydrochloric acid (37 wt%) of 20.5. 20.5 g stannous chloride dihydrate precooled to 5 ℃ is dripped. After the dripping is finished, the reaction solution is stirred for 1.5 hours at the temperature of minus 10 ℃, then the temperature is increased to 5 ℃ for reaction for 18 hours, after the reaction is finished, the solvent is removed by rotary evaporation, the isopropanol 75 ml is added, the stirring is carried out for 2 hours, the filtration is carried out, the filter cake is washed once by the isopropanol, the filtration is carried out, and the filter cake is dried in vacuum to obtain the product 4.6 g of the intermediate I.
4.6 g of intermediate I,5.1 g of methyl isopropyl ketone and 50 mL of acetic acid are added into a 100 mL reaction bottle, the mixture is reacted for 2 hours at 120 ℃, the mixture is cooled to room temperature after the reaction is finished, the solvent is removed by rotary evaporation, ethyl acetate 80 ml and pure water 80 ml are added, the mixture is filtered after stirring for 30 minutes, the filtrate is separated, the aqueous phase is extracted once by 60ml of ethyl acetate, the organic phases are combined, saturated saline is washed once, anhydrous sodium sulfate is dried, the mixture is filtered, the filtrate is rotary evaporated to dryness, silica gel is purified by column chromatography, the eluent is methylene dichloride and methanol=95:5 (mass ratio), rotary drying is collected, and 4.1g of intermediate II is obtained by vacuum drying.
4.1g of intermediate II, 9.0 g of 1, 4-butanesultone are added into a 100 mL reaction bottle, then the reaction is carried out for 12 hours at 130 ℃, the reaction is cooled to room temperature after the completion of the reaction, ethyl acetate 60ml is added, the mixture is heated and refluxed, the mixture is cooled to room temperature after stirring for 1 hour, the mixture is filtered, the filter cake is added with 60ml of ethyl acetate again, the mixture is filtered after stirring for 2 hours, the filter cake is collected, and the filter cake is dried in vacuum to obtain 4.7 g of intermediate III.
100 4.7 g intermediate III,0.7 g of 3, 4-dihydroxyl-3-cyclobutene-1, 2-dione, 25 mL toluene and 25 mL n-butanol are added into a mL reaction bottle, then the reaction is carried out for 3 hours at 160 ℃, after the reaction is finished, heating is stopped, the reaction is cooled to room temperature, 0.6 mL sodium hydroxide aqueous solution (0.85 g/mL) is dropwise added, stirring is carried out for 30 minutes, solid is separated out, filtering is carried out, a filter cake is collected, silica gel is purified by passing through a column, eluting agent is dichloromethane to methanol=90 to 10 (mass ratio), spin-drying is collected, and 2.5g of a final product of the compound 2 is obtained through vacuum drying.
According to the first or second embodiment, the starting materials are changed to obtain the compounds of table 1, in particular, the conventional techniques; FIG. 2 is a mass spectrum of Compound 2; FIG. 3 is a mass spectrum of Compound 3; FIG. 4 is a mass spectrum of Compound 4; figure 5 is a mass spectrum of compound 5.
Example III
FIG. 6 is spectral data for Compound 1, excitation 634nm, emission 661nm, red dye.
1. Preparing a lysosome staining stock solution: taking a jar with a cover, adding 10 mg compound 1 powder, adding 20 mL DMSO solution, diluting with sterilized water until the OD is 65 (OD) Standard of ) Obtaining the lysosome staining stock solution.
2. Lysosome dye solution staining cells
(1) Cell preparation: cells were plated on the day before the experiment, 1.5X10 cells were plated at 100. Mu.L per well of 96 well plate 4 Individual hela cells, i.e.at a cell concentration of 1.5X10 5 Culturing in basic culture medium (DMEM high sugar liquid culture medium) at 37deg.C and 5% CO 2 );
(2) Preparing a dyeing working solution: diluting the prepared lysosome staining stock solution with a basic culture medium according to the mass ratio of 1:20000 to obtain a staining working solution, and preheating at 37 ℃ for later use; at this time, the concentration of Compound 1 was 2.5X10 -5 mg/mL(0.04μmol/L);
(3) Dyeing: removing the cell culture medium, cleaning twice by 1 XPBS, adding 100 mu L of staining working solution into each hole, and incubating for 15 minutes at 37 ℃ in a dark place; after completion, the dye solution was aspirated, washed three times with 1 XPBS, and finally 50. Mu.L of 1 XPBS was added to prevent the cells from drying out, and observed with a fluorescence microscope, see FIG. 7.
Example IV
1. Preparing a lysosome staining stock solution: taking a jar with a cover, adding 10 mg compound 2 powder, adding 20 mL DMSO solution, diluting with sterilized water until the OD is 65 (OD) Standard of ) Obtaining the lysosome staining stock solution.
2. Lysosome dye solution staining cells
(1) Cell preparation: cells were plated on the day before the experiment, 1.5X10 cells were plated at 100. Mu.L per well of 96 well plate 4 The hela cells were cultured overnight (37 ℃ C., 5% CO) in a basal medium (DMEM high-sugar liquid medium) in an incubator 2 );
(2) Preparing a dyeing working solution: diluting the prepared lysosome staining stock solution with a basic culture medium to obtain a staining working solution, and preheating at 37 ℃ for later use; at this time, the concentration of Compound 2 was 0.027. Mu. Mol/L;
(3) Dyeing: removing the cell culture medium, cleaning twice by 1 XPBS, adding 100 mu L of staining working solution into each hole, and incubating for 10 minutes at 37 ℃ in a dark place; after completion, the dye solution was aspirated, washed three times with 1 XPBS, and finally 50. Mu.L of 1 XPBS was added to prevent the cells from drying out, and observed with a fluorescence microscope, see FIG. 8.
Example five
1. Preparing a lysosome staining stock solution: taking a jar with a cover, adding 10 mg compound 3 powder, adding 20 mL DMSO solution, diluting with sterilized water until the OD is 65 (OD) Standard of ) Obtaining the lysosome staining stock solution.
2. Lysosome dye solution staining cells
(1) Cell preparation: cells were plated on the day before the experiment, 1.5X10 cells were plated at 100. Mu.L per well of 96 well plate 4 The hela cells were cultured overnight (37 ℃ C., 5% CO) in a basal medium (DMEM high-sugar liquid medium) in an incubator 2 );
(2) Preparing a dyeing working solution: diluting the prepared lysosome staining stock solution with a basic culture medium to obtain a staining working solution, and preheating at 37 ℃ for later use; at this time, the concentration of Compound 3 was 0.046. Mu. Mol/L;
(3) Dyeing: removing the cell culture medium, cleaning twice by 1 XPBS, adding 100 mu L of staining working solution into each hole, and incubating for 15 minutes at 37 ℃ in a dark place; after completion, the dye solution was aspirated, washed three times with 1 XPBS, and finally 50. Mu.L of 1 XPBS was added to prevent the cells from drying out, and observed with a fluorescence microscope, see FIG. 9.
Example six
According to the protocol of embodiment III, target cells were stained with Compound 1, washed with PBS buffer, and re-treated with commercially available LysoTracker ™ Green DND-26 (Invitrogen) TM Catalog number: L7526) was co-localized stained according to the instructions of its operation, and the result showed that compound 1 and the purchased control were the same function (yellow after co-staining of red and green), see FIG. 10.
Example seven
According to the specific operation scheme of the fifth embodiment, the concentration of the dyeing working solution is 50nM, and the dyeing results of the compound 3 and the existing high-performance dye Lysostracker ™ Deep Red (catalyst number: L12492) are respectively shown in FIG. 11 and FIG. 12, and it can be seen that the compound of the invention has obviously high brightness as a dye under the same concentration of the dyeing solution.
The lysosome probe disclosed by the prior art is mainly blue light and yellow light, can freely penetrate cell membranes, marks living cells, can specifically mark and track acid organelles in the living cells at a low nanomolar concentration, can realize one-step dyeing, specifically marks acid organelle lysosomes in the living cells, and is rapidly introduced at the nanomolar concentration level to detect the cells. Meanwhile, compared with other lysosome dyes, the dye has more obvious dyeing effect, is not easy to quench and has better optical stability, and can be kept in cells for a long time. The excitation emission wavelength of the invention is closer to the near infrared spectrum, and the invention can also meet the requirement of multicolor dyeing.
Claims (7)
1. A lysosomal targeting fluorescent probe, which is one of the following chemical formulas:
;
wherein R is 1 、R 2 Independently selected from hydrogen, alkyl, ether groups; r is R 3 、R 4 Independently selected from hydrogen, alkyl, alkylsulfonic acid ions;
R 1 、R 2 the number of carbon atoms of the alkyl group in the formula (I) is 2-6, R 3 、R 4 The number of carbon atoms of the alkyl group is 2 to 12; the carbon number of the alkyl in the ether group is 2-6; the alkylsulfonic acid is (CH) 2 )nSO 3 H, n is 2-8; the alkylsulfonic acid ion is (CH) 2 )mSO 3 - M is 2 to 8.
2. The lysosomal targeting fluorescent probe of claim 1, wherein the lysosomal targeting fluorescent probe has or does not have a coordinating ion.
3. The method for preparing the lysosome targeted fluorescent probe according to claim 1, wherein an indole compound and a hydroxycyclobutene compound are reacted to obtain the lysosome targeted fluorescent probe; the chemical structural formula of the indole compound is one or two of the following structural formulas:
、/>、/>。
4. the method for preparing a lysosome targeted fluorescent probe according to claim 3, wherein the reaction temperature of the indole compound and the hydroxycyclobutene compound is 120-200 ℃ for 2-6 hours.
5. Use of the lysosomal targeting fluorescent probe according to claim 1 for the preparation of lysosomal probes.
6. Use of the lysosome targeted fluorescent probe of claim 1 in the preparation of a cell developer.
7. The use according to claim 6, wherein the cell development is red development.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210711226.7A CN114957082B (en) | 2022-06-22 | 2022-06-22 | Lysosome targeting fluorescent probe and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210711226.7A CN114957082B (en) | 2022-06-22 | 2022-06-22 | Lysosome targeting fluorescent probe and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114957082A CN114957082A (en) | 2022-08-30 |
CN114957082B true CN114957082B (en) | 2024-03-26 |
Family
ID=82964875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210711226.7A Active CN114957082B (en) | 2022-06-22 | 2022-06-22 | Lysosome targeting fluorescent probe and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114957082B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103030989A (en) * | 2012-12-10 | 2013-04-10 | 北京化工大学 | Synthesis method of water-soluble squarylium indocyanine multifunctional cell fluorescent dye |
CN105238093A (en) * | 2015-09-02 | 2016-01-13 | 北京化工大学 | Amphiphilic indole squarylium cyanine dye and application thereof in long-acting marking of lysosome |
JP2017503004A (en) * | 2013-10-31 | 2017-01-26 | ベス・イスラエル・ディーコネス・メディカル・センター,インコーポレイテッド | Near-infrared fluorescence contrast bioimaging agent and method of use thereof |
KR101842495B1 (en) * | 2017-03-13 | 2018-03-27 | 한국화학연구원 | Novel squarylium compounds, resin composition for absorbing near infrared ray including the same and absorbing near infrared ray blocking filter manufactured by using this |
CN112645874A (en) * | 2020-12-24 | 2021-04-13 | 皖南医学院 | Lysosome targeted fluorescent probe and preparation method and application thereof |
CN113845462A (en) * | 2021-10-26 | 2021-12-28 | 常熟理工学院 | Lysosome fluorescent probe, preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7282373B2 (en) * | 2004-12-23 | 2007-10-16 | Rutgers, The State University Of New Jersey | Ultra-high specificity fluorescent labeling |
WO2019032683A2 (en) * | 2017-08-08 | 2019-02-14 | Board Of Trustees Of Michigan State University | Tunable luminescent organic salts for enhanced imaging and photodynamic therapy |
US20200368371A1 (en) * | 2019-05-23 | 2020-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Dye-protein complex for nir ii and photoacoustic imaging |
-
2022
- 2022-06-22 CN CN202210711226.7A patent/CN114957082B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103030989A (en) * | 2012-12-10 | 2013-04-10 | 北京化工大学 | Synthesis method of water-soluble squarylium indocyanine multifunctional cell fluorescent dye |
JP2017503004A (en) * | 2013-10-31 | 2017-01-26 | ベス・イスラエル・ディーコネス・メディカル・センター,インコーポレイテッド | Near-infrared fluorescence contrast bioimaging agent and method of use thereof |
CN105238093A (en) * | 2015-09-02 | 2016-01-13 | 北京化工大学 | Amphiphilic indole squarylium cyanine dye and application thereof in long-acting marking of lysosome |
KR101842495B1 (en) * | 2017-03-13 | 2018-03-27 | 한국화학연구원 | Novel squarylium compounds, resin composition for absorbing near infrared ray including the same and absorbing near infrared ray blocking filter manufactured by using this |
CN112645874A (en) * | 2020-12-24 | 2021-04-13 | 皖南医学院 | Lysosome targeted fluorescent probe and preparation method and application thereof |
CN113845462A (en) * | 2021-10-26 | 2021-12-28 | 常熟理工学院 | Lysosome fluorescent probe, preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114957082A (en) | 2022-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | A ratiometric lysosomal pH probe based on the coumarin–rhodamine FRET system | |
CN111303102B (en) | Nitroreductase responsive hypoxic probe compound and preparation and application thereof | |
JP2017519844A (en) | Azetidine-substituted fluorescent compound | |
CN113072937B (en) | Lipid drop targeted carbon dot, preparation method and application | |
CN110156688B (en) | Fluorescent probe for detecting polarity of targeted endoplasmic reticulum and application thereof | |
CN108864058A (en) | A kind of xanthone fluorochrome and application | |
CN105218538A (en) | Tonka bean camphor-pyridine derivate replaced and its production and use | |
CN108219780B (en) | Near-infrared fluorescent probe and preparation method and application thereof | |
CN105367566B (en) | Substituted cumarin-thiazole orange derivative and its preparation method and application | |
CN113061109B (en) | Morpholine-pyridine-merocyanine derivative fluorescent probe and preparation method and application thereof | |
CN113651834A (en) | Fluorescent probe based on dithienobenzene derivative and application of fluorescent probe in cell lipid drop imaging | |
CN112939918B (en) | Coumarin derivative CTT and synthesis method and application thereof | |
CN114957082B (en) | Lysosome targeting fluorescent probe and preparation method and application thereof | |
CN115650897B (en) | Fluorescent probe for simultaneously detecting Cys and mitochondrial viscosity and preparation method and application thereof | |
CN112341419A (en) | Single-molecule fluorescent probe capable of distinguishing imaging lipid drop and endoplasmic reticulum simultaneously and application thereof | |
CN109369565B (en) | Benzothiazole derivative and preparation method and application thereof | |
CN114702447B (en) | Naphthalimide derivative and preparation method and application thereof | |
CN105348268A (en) | Substituted carbazole-indole sulfonate derivative, and preparation method therefor and use thereof | |
CN114805297A (en) | Large-Stokes-shift near-infrared emission dye and preparation method and application thereof | |
Fukumoto et al. | Acid responsiveness of emissive morpholinyl aminoquinolines and their use for cell fluorescence imaging | |
CN112480134B (en) | Pair of isomers, preparation method and application thereof | |
US20230159819A1 (en) | Neutral fluorescent mitochondrial marker as amide derivative, and preparation method and use thereof | |
CN108840818B (en) | Synthesis and application of colorimetric carbazole fluorescent probe for detecting hydrogen sulfide | |
CN114436947B (en) | Fluorescent probe with double responses to viscosity and nitroreductase as well as preparation method and application thereof | |
CN113717544B (en) | Rapid and long-time lysosome or cell nucleus targeted near-infrared staining reagent based on aminofluorene skeleton, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |